Netmarble's New Game 'SOL: enchant' Payment Promotion with the Three Major Telecom Carriers
Up to 20% bill discount with KT and up to 10% with SKT and LG U+ when using carrier billing on Google Play
Enter the promotion through each telecom provider’s event page; the promotion runs through July 8
[Edaily Reporter Ahn Yu-ri] #Netmarble announced on the 19th that it will launch a payment partnership promotion for its new MMORPG (massively multiplayer online role-playing game) “SOL: enchant” in collaboration with South Korea’s three major telecom carriers (KT, SKT, and LG U+).
This promotion will run until July 8. Users can participate by registering through each carrier’s event page and then making a purchase on Google Play using their carrier’s payment method.
Promotional benefits include a base discount of 7,000 won for KT users, along with a bill discount of up to 20% (up to 250,000 won off for payments of 300,000 won or more). SKT and LG U+ users will receive a base discount of 5,000 won, along with a bill discount of up to 10% (up to 200,000 won off for payments of 100,000 won or more).
Meanwhile, Netmarble is hosting various events to celebrate the launch of “SOL: enchant.” The drop rates for rewards from all boss monsters have been tripled to provide more generous rewards, and the first player on each server to reach Level 50 will receive the Hero-grade “Ring of Baltaros.”
“SOL: enchant” is a new MMORPG that introduces a unique “Divine Authority” system under the motto of an “Omniscient MMORPG.” Developed by Altnine—a new studio led by the core team behind “Lineage M”—and published by Netmarble, the game supports both PC and mobile platforms.
“Credit Checkpoint” is a column that assesses the credit rating risks of companies preparing to issue corporate bonds by examining their financial structure and cash flows. We evaluate a company’s sho…
Hong Won-sik, former chairman of NamyangDairyProducts, lost his lawsuit against NamyangDairyProducts(003920)seeking 44.35775 billion won in severance pay. The court dismissed Mr. Hong’s claim for seve…
SOTIO Biotech, a partner company of LigaChem Biosciences(141080), announced on the 27th that SOT106, an antibody-drug conjugate (ADC) currently under development, has been granted Fast Track designati…